Drug Type Monoclonal antibody |
Synonyms CURAB-10, HUB10G5, SYB 010 + [1] |
Target |
Mechanism MICA inhibitors(MHC class I polypeptide-related sequence A inhibitors), MICB inhibitors(MHC class I polypeptide-related sequence B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | - |